If Kawasaki disease is treated early, there's less of a chance of coronary artery damage. Children with the condition get high doses of intravenous immunoglobulin as soon as the diagnosis is made. They're also given very high doses of acetylsalicylic acid* (ASA). After their fever has gone down, children with Kawasaki disease are given a lower dose of ASA for a few months. This treatment prevents the blood from clotting in case there is some damage to the coronary arteries.
Small coronary artery aneurysms resulting from Kawasaki disease are treated with ASA. For large aneurysms, other blood thinning agents (e.g., warfarin, clopidogrel, or heparin) may be added to the ASA treatment. Small aneurysms go away within a year, but often leave weakened arteries that can cause heart problems in the future. For example, children with Kawasaki disease can have heart attacks 10 years after first being diagnosed with the condition.
If their coronary arteries haven't been damaged, children with the condition can make a complete recovery. Kawasaki disease is fatal in less than 1% of cases, where half of the fatalities occur within the first month.
*All medications have both common (generic) and brand names. The brand name is what a specific manufacturer calls the product (e.g., Tylenol®). The common name is the medical name for the medication (e.g., acetaminophen). A medication may have many brand names, but only one common name. This article lists medications by their common names. For information on a given medication, check our Drug Information database. For more information on brand names, speak with your doctor or pharmacist.
All material copyright MediResource Inc. 1996 – 2017. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Source: www.medbroadcast.com/condition/getcondition/Kawasaki-Disease